In vitro metabolic conversion of aflatoxins and benzo(alpha)pyrene to nucleic acid-binding metabolites
- PMID: 234034
In vitro metabolic conversion of aflatoxins and benzo(alpha)pyrene to nucleic acid-binding metabolites
Abstract
An aflatoxin B1 metabolite was found to become covalently bound to rat liver RNA and calf thymus DNA in vitro, and it formed complexes with increased spectral absorbance in the 360 nm region. The formation of such complexes was reduced nicotinamide adenine dinucleotide phosphate and microsome dependent, was inhibited by theta-diethylaminoethyl diphenylpropylacetate-HC1, and by CO and N2, when the latter were used to replace the gas phase of the incubations. The formation of the complexes was enhanced about 2-fold with cicrosomes from phenobarbital-treated rats but not from 3-methylcholanthrene-treated rats. More binding was observed with DNA than RNA. Dentured DNA was about 70% as effective as native DNA. Nucleic acids from various sources showed the following order of binding potency: DNA from Micrococcus luteus greater than DNA from calf thymus equal to DNA from rat liver greater than RNA from rat liver greater than transfer RNA from rat liver. In the presence of reduced nicotinamide adenine dinucleotide phosphate and microsomes from phenobarbital-treated rats, aflatoxin G1 was also converted into metabolite(s) that became covalently bound to nucleic acids and formed complexes with increased spectral absorbances in the 360 nm region: this reaction was also inhibited by theta-diethylaminoethyl diphenylpropylacetate-HC1. Under the same conditions, aflatoxin B2, aflatoxin G2, aflatoxin B2a, and "Compound 11," which lack a C2-C3 double bond, did not show any noticeable binding to either DNA or RNA. These data strongly support the concept that the microsomal mixed-funciton oxygenase-catalyzed oxidation of the C2-C3 double bond of aflatoxins is a prerequisite for the formation of nucleic acid-binding metabolites. Microsomes from untreated, phenobarbital-treated, and 3-methylcholanthrene-treated rats were compared in vitro for their ability to catalyze the formation of DNA-binding metabolites from aflatozin B1 and benzo(a)pyrene. In assays involving benzo(a)pyrene, microsomes from 3-methylcholanthrene-treated rats were 12- and 5-fold more active than microsomes from untreated and phenobar-bital-treated rats, respectively. This is in contrast to the results obtained with aflatoxin B1 and suggests that different enzymes in the hepatic microsomal mixed-function oxygenase complex are involved in the generation of reactive metabolites from various polycyclic hydrocarbons.
Similar articles
-
Metabolism of a prototype mycotoxin, aflatoxin B1, and its genetic regulation.Mycopathologia. 1978 Dec 18;65(1-3):13-28. doi: 10.1007/BF00447170. Mycopathologia. 1978. PMID: 106281 Review. No abstract available.
-
Microsome-dependent binding of benzo(alpha)pyrene and aflatoxin B1 to DNA, and benzo(alpha)pyrene binding to aflatoxin-conjugated DNA.Cancer Res. 1974 Dec;34(12):3289-95. Cancer Res. 1974. PMID: 4154143 No abstract available.
-
Binding of [3H]benzo(a)pyrene to natural and synthetic nucleic acids in a subcellular microsomal system.Cancer Res. 1975 Aug;35(8):2191-8. Cancer Res. 1975. PMID: 238738
-
Influence of inducers and inhibitors of mixed-function oxidasts on benzo(a)pyrene binding to the DNA of rat liver nuclei.Cancer Res. 1977 May;37(5):1443-9. Cancer Res. 1977. PMID: 856463
-
Variables influencing DNA-binding in mouse liver.Arch Toxicol Suppl. 1987;10:180-9. doi: 10.1007/978-3-642-71617-1_17. Arch Toxicol Suppl. 1987. PMID: 3107523 Review.
Cited by
-
Inhibition of liver microsomal epoxide hydrase by cyproheptadine epoxide.Experientia. 1977 Apr 15;33(4):484-5. doi: 10.1007/BF01922224. Experientia. 1977. PMID: 862740 No abstract available.
-
Excretion of aflatoxin B1 as a glutathione conjugate.Eur J Drug Metab Pharmacokinet. 1981;6(4):265-8. doi: 10.1007/BF03189524. Eur J Drug Metab Pharmacokinet. 1981. PMID: 6800796
-
Indoor mold, toxigenic fungi, and Stachybotrys chartarum: infectious disease perspective.Clin Microbiol Rev. 2003 Jan;16(1):144-72. doi: 10.1128/CMR.16.1.144-172.2003. Clin Microbiol Rev. 2003. PMID: 12525430 Free PMC article. Review.
-
Metabolism of a prototype mycotoxin, aflatoxin B1, and its genetic regulation.Mycopathologia. 1978 Dec 18;65(1-3):13-28. doi: 10.1007/BF00447170. Mycopathologia. 1978. PMID: 106281 Review. No abstract available.
-
Mutagenicity of aflatoxins related to their metabolism and carcinogenic potential.Proc Natl Acad Sci U S A. 1976 Jul;73(7):2241-4. doi: 10.1073/pnas.73.7.2241. Proc Natl Acad Sci U S A. 1976. PMID: 781672 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Miscellaneous